Incyte Corp (INCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 41,197 | 95,473 | 219,263 | 194,167 | 156,962 |
| Gross Profit | 41,197 | 95,473 | 219,263 | 194,167 | 156,962 |
| Operating Expenses | 190,549 | 227,787 | 414,334 | 256,757 | 184,068 |
| Operating Income | -149,352 | -132,314 | -195,071 | -62,590 | -27,106 |
| Interest Expense | 9,561 | 9,797 | 10,128 | 10,529 | 316 |
| Other Income | -7,131 | 9,259 | 20,615 | 43,589 | -146 |
| Pre-tax Income | -166,044 | -132,852 | -184,584 | -29,530 | -27,568 |
| Income Tax | 342 | 945 | 930 | 205 | -800 |
| Net Income Continuous | -166,386 | -133,797 | -185,514 | -29,735 | -26,768 |
| Net Income Discontinuous | -77 | -3,088 | N/A | N/A | N/A |
| Net Income | $-166,463 | $-136,885 | $-183,235 | $-29,735 | $-26,768 |
| EPS Basic Total Ops | -2.33 | -2.03 | -2.77 | -0.47 | -0.48 |
| EPS Basic Continuous Ops | -2.33 | -1.98 | -2.80 | -0.47 | -0.48 |
| EPS Basic Discontinuous Ops | 0.00 | -0.05 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.33 | -2.03 | -2.77 | -0.47 | -0.48 |
| EPS Diluted Continuous Ops | -2.33 | -1.98 | -2.80 | -0.47 | -0.48 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.05 | N/A | N/A | N/A |
| EBITDA(a) | $-132,457 | $-110,206 | $-148,661 | $-28,260 | $1,000 |